A phase-2 study of pembrolizumab in patients with biologically selected subtypes of relapsed/refractory aggressive lymphomas.
Journal: Leukemia & Lymphoma
Published:
Authors
Mwanasha Merrill, Robert Redd, David Fisher, Jeremy Abramson, Jeffrey Barnes, Jaehyuk Choi, Caron Jacobson, Austin Kim, Matthew Lunning, Hallie Jester, Erin Jeter, Mikaela Mcdonough, Philippe Armand, Eric Jacobsen
Relevant Conditions